| EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth LV Bownes, AP Williams, R Marayati, LL Stafman, H Markert, CH Quinn, ... PLoS One 16 (3), e0246244, 2021 | 21 | 2021 |
| Focal adhesion kinase inhibition contributes to tumor cell survival and motility in neuroblastoma patient-derived xenografts LL Stafman, AP Williams, R Marayati, JM Aye, HR Markert, EF Garner, ... Scientific Reports 9 (1), 13259, 2019 | 20 | 2019 |
| CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells R Marayati, LL Stafman, AP Williams, LV Bownes, CH Quinn, HR Markert, ... Cancer gene therapy 29 (5), 558-572, 2022 | 11 | 2022 |
| Targeting high-risk neuroblastoma patient-derived xenografts with oncolytic virotherapy CH Quinn, AM Beierle, SC Hutchins, R Marayati, LV Bownes, JE Stewart, ... Cancers 14 (3), 762, 2022 | 9 | 2022 |
| Investigation of PP2A and its endogenous inhibitors in neuroblastoma cell survival and tumor growth AP Williams, EF Garner, AM Waters, LL Stafman, JM Aye, H Markert, ... Translational Oncology 12 (1), 84-95, 2019 | 9 | 2019 |
| Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts R Marayati, LV Bownes, CH Quinn, N Wadhwani, AP Williams, ... Journal of pediatric surgery 56 (6), 1165-1173, 2021 | 5 | 2021 |
| The effects of protein phosphatase 2A activation with novel tricyclic sulfonamides on hepatoblastoma LV Bownes, JR Julson, CH Quinn, SC Hutchins, MH Erwin, HR Markert, ... Journal of Pediatric Surgery 58 (6), 1145-1154, 2023 | 4 | 2023 |
| Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype R Marayati, JR Julson, LV Bownes, CH Quinn, SC Hutchins, AP Williams, ... Journal of pediatric surgery 57 (6), 1018-1025, 2022 | 4 | 2022 |
| Downregulation of PDGFRss signaling overcomes crizotinib resistance in a TYRO3 and ALK mutated neuroendocrine-like tumor CH Quinn, AM Beierle, AP Williams, R Marayati, LV Bownes, HR Markert, ... Translational Oncology 14 (7), 101099, 2021 | 4 | 2021 |
| The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor JM Aye, LL Stafman, AP Williams, EF Garner, JE Stewart, JC Anderson, ... Oncotarget 10 (53), 5534, 2019 | 4 | 2019 |
| PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma N Wadhwani, HR Markert, R Marayati, LV Bownes, CH Quinn, JM Aye, ... Journal of pediatric surgery 56 (6), 1157-1164, 2021 | 3 | 2021 |
| PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4 R Marayati, J Julson, LV Bownes, CH Quinn, LL Stafman, AM Beierle, ... Clinical & experimental metastasis 39 (6), 899-912, 2022 | 2 | 2022 |
| Using 3D-bioprinted models to study pediatric neural crest-derived tumors CH Quinn, AM Beierle, JR Julson, ME Erwin, H Alrefai, HR Markert, ... International Journal of Bioprinting 9 (4), 2023 | 1 | 2023 |
| Rapid characterization of solid tumors using resonant sensors AM Beierle, CH Quinn, HR Markert, A Carr, R Marayati, LV Bownes, ... ACS omega 7 (36), 32690-32700, 2022 | 1 | 2022 |
| Metastatic Hepatoblastoma Cells Exhibit a Distinct Cancer Stem Cell-like Phenotype Which Is Attenuated by PIM Inhibition R Marayati, JR Julson, LV Bownes, CH Quinn, SC Hutchins, HR Markert, ... Pediatrics 149 (1 Meeting Abstracts February 2022), 892-892, 2022 | | 2022 |
| Metastatic Hepatoblastoma Cells Exhibit a Distinct Cancer Stem Cell-Like Phenotype R Marayati, LV Bownes, CH Quinn, SC Hutchins, HR Markert, AM Beierle, ... Journal of the American College of Surgeons 233 (5), S179, 2021 | | 2021 |
| MEK1/2 Inhibition as a Therapeutic Target in anNRAS-Mutated Pediatric Neuroendocrine Tumor CH Quinn, AP Williams, R Marayati, HR Markert, JM Aye, JE Stewart, ... Journal of the American College of Surgeons 231 (4), S206-S207, 2020 | | 2020 |
